Ms. Arjoca’s primary areas of expertise include working across the M&A lifecycle, from carve-out assessment to implementation, deal execution and post-merger integration. She brings corporate experience in healthcare and real estate, and has advised clients in several industries, including digital services, industrial manufacturing, financial services, healthcare and real estate. 

Ms. Arjoca’s select engagements include leading PMO for the carve-out planning and execution of the unified communication and collaboration business (50+ countries, 3000+ FTE) of a global player, sold to a strategic competitor; country separation PMO for the carve-out and ensuring Day 1 standalone readiness (new ERP system) for the environmental science business of a German stock-listed Pharma corporate (100+ countries, 900+ FTE) sold to a private equity firm; and the carve-out and ensuring Day 1 readiness of the global prescription dermatology business of a German stock-listed Pharma corporate, sold to a leading Pharma company. 

Prior to joining A&M, Ms. Arjoca was a Partner at a Big 4 company in Vienna, where she set up the Value Creation in Deals team. She also worked with a private equity healthcare fund in Italy, where she was responsible for defining the target operating model, multidisciplinary performance improvement and building up mid-management in preparation for a subsequent exit. 

Additionally, Ms. Arjoca spent six years with an Austrian listed real estate investment company (ATX5), where she reported to the Board of Directors and had fiduciary and commercial responsibility for €1+ billion AuM in CEE, SEE and Turkey. In this role, she was responsible for providing “fix, sell, buy or wind-down” option analysis and executing accordingly.

Ms. Arjoca earned a PhD in international business (analyzing cross-border investment strategies of large Austrian corporates). She is fluent in Romanian (native), German, English, French, Italian and Spanish.